COMMON STOCK PURCHASE WARRANT CNS Pharmaceuticals, Inc.Common Stock Purchase Warrant • January 6th, 2022 • CNS Pharmaceuticals, Inc. • Pharmaceutical preparations
Contract Type FiledJanuary 6th, 2022 Company IndustryTHIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on ______________[1] (the “Termination Date”) but not thereafter, to subscribe for and purchase from CNS Pharmaceuticals, Inc., a Nevada corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • January 6th, 2022 • CNS Pharmaceuticals, Inc. • Pharmaceutical preparations
Contract Type FiledJanuary 6th, 2022 Company IndustryThis Registration Rights Agreement (this “Agreement”) is made and entered into as of January 5, 2022, by and between CNS Pharmaceuticals, Inc., a Nevada corporation (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • January 6th, 2022 • CNS Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJanuary 6th, 2022 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of January 5, 2021, between CNS Pharmaceuticals, Inc., a Nevada corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
PRE-FUNDED COMMON STOCK PURCHASE WARRANT CNS Pharmaceuticals, Inc.Pre-Funded Common Stock Agreement • January 6th, 2022 • CNS Pharmaceuticals, Inc. • Pharmaceutical preparations
Contract Type FiledJanuary 6th, 2022 Company IndustryTHIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and until this Warrant is exercised in full (the “Termination Date”) but not thereafter, to subscribe for and purchase from CNS Pharmaceuticals, Inc., a Nevada corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
STRICTLY CONFIDENTIAL CNS Pharmaceuticals, Inc.Underwriting Agreement • January 6th, 2022 • CNS Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJanuary 6th, 2022 Company Industry Jurisdiction